Literature DB >> 29534959

The urinary organic acids profile in single large-scale mitochondrial DNA deletion disorders.

Michela Semeraro1, Sara Boenzi2, Rosalba Carrozzo3, Daria Diodato3, Diego Martinelli2, Giorgia Olivieri2, Giacomo Antonetti2, Elisa Sacchetti2, Giulio Catesini2, Cristiano Rizzo2, Carlo Dionisi-Vici2.   

Abstract

Single large-scale mitochondrial DNA deletions disorders are classified into three main phenotypes with frequent clinical overlap: Pearson marrow-pancreas syndrome (PMS), Kearns-Sayre syndrome (KSS) and chronic progressive external ophtalmoplegia (PEO). So far, only few anecdotal studies have reported on the urinary organic acids profile in this disease class. In this single-center retrospective study, we performed quantitative evaluation of urinary organic acids in a series of 15 pediatric patients, 7 with PMS and 8 with KSS. PMS patients showed an organic acids profile almost constantly altered, whereas KSS patients frequently presented with normal profiles. Lactate, 3-hydroxybutyrate, 3-hydroxyisobutyrate, fumarate, pyruvate, 2-hydroxybutyrate, 2-ethyl-3-hydroxypropionate, and 3-methylglutaconate represented the most frequent metabolites observed in PMS urine. We also found novel metabolites, 3-methylglutarate, tiglylglycine and 2-methyl-2,3-dihydroxybutyrate, so far never reported in this disease. Interestingly, patients with a disease onset as PMS evolving overtime into KSS phenotype, presented persistent and more pronounced alterations of organic acid signature than in patients with a pure KSS phenotype. Our study shows that the quantitative analysis of urinary organic acid profile represents a helpful tool for the diagnosis of PMS and for the differential diagnosis with other inherited diseases causing abnormal organic acidurias.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gas chromatography–mass spectrometry; Kearns-Sayre syndrome; Pearson marrow-pancreas syndrome; Single large-scale mitochondrial DNA deletion disorders; Urinary organic acids

Mesh:

Substances:

Year:  2018        PMID: 29534959     DOI: 10.1016/j.cca.2018.03.002

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

Review 1.  3-Methylglutaric acid in energy metabolism.

Authors:  Dylan E Jones; Leanne Perez; Robert O Ryan
Journal:  Clin Chim Acta       Date:  2019-11-12       Impact factor: 3.786

2.  Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.

Authors:  Rohit Sharma; Bryn Reinstadler; Kristin Engelstad; Owen S Skinner; Erin Stackowitz; Ronald G Haller; Clary B Clish; Kerry Pierce; Melissa A Walker; Robert Fryer; Devin Oglesbee; Xiangling Mao; Dikoma C Shungu; Ashok Khatri; Michio Hirano; Darryl C De Vivo; Vamsi K Mootha
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

3.  Kearns-Sayre Syndrome Minus: Two Cases of Identical Large-Scale Mitochondrial DNA Deletions with Presentations outside the Classical Triad.

Authors:  Shir Wey Gloria Pang; Hencher Han Chih Lee; Carol Ng Wing Kei; Eric Kin Cheong Yau; Joannie Hui
Journal:  Case Rep Genet       Date:  2022-04-23

Review 4.  Recent topics: the diagnosis, molecular genesis, and treatment of mitochondrial diseases.

Authors:  Kei Murayama; Masaru Shimura; Zhimei Liu; Yasushi Okazaki; Akira Ohtake
Journal:  J Hum Genet       Date:  2018-11-21       Impact factor: 3.172

5.  Comprehensive clinical and genetic work-up of patients carrying single mtDNA deletions is warranted.

Authors:  Josef Finsterer
Journal:  Transl Pediatr       Date:  2021-06

6.  Identification of Serum Biomarkers Associated With Emergence Agitation After General Anesthesia in Adult Patients: A Metabolomics Analysis.

Authors:  Xinning Mi; Jingshu Hong; Zhengqian Li; Taotao Liu; Qian Wang; Jiansuo Zhou; Yitong Li; Xiaoxiao Wang; Yi Yuan; Ning Yang; Yongzheng Han; Yang Zhou; Xiangyang Guo; Yue Li; Dengyang Han
Journal:  Front Med (Lausanne)       Date:  2022-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.